NYSE:RADRite Aid Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Rite Aid Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $17.29 +0.23 (+1.35 %) (As of 07/1/2020 04:00 PM ET) Add Compare Share Today's Range$16.98Now: $17.29▼$18.2650-Day Range$12.35MA: $13.44▼$17.3152-Week Range$5.04Now: $17.29▼$23.88Volume6.00 million shsAverage Volume5.54 million shsMarket Capitalization$945.81 millionP/E RatioN/ADividend YieldN/ABeta0.88 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and provides preventative services, such as screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order and specialty pharmacy services, as well as drug benefits under the federal government's Medicare Part D program. As of April 11, 2019, the company operated 2,469 stores in 18 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.Read More Beat the Market (BTM) Rank™ 0.9 Analyst's Opinion Consensus RatingRite Aid has received a consensus rating of Hold. The company's average rating score is 1.75, and is based on no buy ratings, 3 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $17.50, Rite Aid has a potential upside of 1.2% from its current price of $17.29.Amount of Analyst CoverageRite Aid has only been the subject of 2 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesRite Aid has received 783 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRite Aid has received 791 “underperform” votes. (Add your “underperform” vote.)Community SentimentRite Aid has received 50.25% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote “Outperform” if you believe RAD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRite Aid does not currently pay a dividend.Dividend GrowthRite Aid does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Rite Aid insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.52% of the stock of Rite Aid is held by insiders.Percentage Held by Institutions53.43% of the stock of Rite Aid is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Rite Aid are expected to grow by 240.00% in the coming year, from $0.50 to $1.70 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rite Aid is -2.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rite Aid is -2.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRite Aid has a P/B Ratio of 1.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.9Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.25 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Drug stores & proprietary stores Sub-IndustryDrug Retail SectorRetail/Wholesale Current SymbolNYSE:RAD Previous Symbol CUSIP76775410 CIK84129 Webwww.riteaid.com Phone717-761-2633Debt Debt-to-Equity Ratio8.61 Current Ratio1.34 Quick Ratio0.64Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio34.58 P/E GrowthN/A Sales & Book Value Annual Sales$21.93 billion Price / Sales0.04 Cash Flow$6.13 per share Price / Cash Flow2.82 Book Value$12.31 per share Price / Book1.40Profitability EPS (Most Recent Fiscal Year)$0.15 Net Income$-452,170,000.00 Net Margins-1.84% Return on Equity1.53% Return on Assets0.13%Miscellaneous Employees48,000 Outstanding Shares54,703,000Market Cap$945.81 million Next Earnings Date9/24/2020 (Estimated) OptionableOptionable RAD Rates by TradingView Receive RAD News and Ratings via Email Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter. Rite Aid (NYSE:RAD) Frequently Asked Questions How has Rite Aid's stock been impacted by COVID-19 (Coronavirus)? Rite Aid's stock was trading at $14.13 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RAD stock has increased by 22.4% and is now trading at $17.29. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Rite Aid? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Rite Aid. When is Rite Aid's next earnings date? Rite Aid is scheduled to release its next quarterly earnings announcement on Thursday, September 24th 2020. View our earnings forecast for Rite Aid. How were Rite Aid's earnings last quarter? Rite Aid Co. (NYSE:RAD) announced its quarterly earnings data on Thursday, June, 25th. The company reported ($0.04) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.38) by $0.34. The business earned $6.03 billion during the quarter, compared to the consensus estimate of $5.61 billion. Rite Aid had a positive return on equity of 1.53% and a negative net margin of 1.84%. The firm's revenue was up 12.2% compared to the same quarter last year. View Rite Aid's earnings history. When did Rite Aid's stock split? How did Rite Aid's stock split work? Rite Aid shares reverse split on the morning of Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split. What guidance has Rite Aid issued on next quarter's earnings? Rite Aid updated its FY21 earnings guidance on Thursday, April, 16th. The company provided earnings per share guidance of ($0.22) - $0.19 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.19. The company issued revenue guidance of $22.5-22.9 billion, compared to the consensus revenue estimate of $22.53 billion. What price target have analysts set for RAD? 4 brokerages have issued 1 year price targets for Rite Aid's shares. Their forecasts range from $17.00 to $18.00. On average, they expect Rite Aid's stock price to reach $17.50 in the next year. This suggests a possible upside of 1.2% from the stock's current price. View analysts' price targets for Rite Aid. Has Rite Aid been receiving favorable news coverage? Media headlines about RAD stock have been trending very negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Rite Aid earned a news impact score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Rite Aid. Who are some of Rite Aid's key competitors? Some companies that are related to Rite Aid include Covetrus (CVET), Petmed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP). View all competitors. What other stocks do shareholders of Rite Aid own? Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Mr. Cooper Group (COOP), Cleveland-Cliffs (CLF), Advanced Micro Devices (AMD), General Electric (ge), Lantronix (LTRX) and Micron Technology (MU). Who are Rite Aid's key executives? Rite Aid's management team includes the following people: Ms. Jocelyn Zazyczny Konrad, Exec. VP & Chief Pharmacy Officer (Age 50)Ms. Heyward Rutledge Donigan B.A., Pres CEO & Director (Age 59)Mr. Matthew Schroeder, CFO & Exec. VP (Age 50)Mr. James J. Peters, Chief Operating Officer (Age 48)Mr. Brian Hoover, Chief Accounting Officer (Age 55) What is Rite Aid's stock symbol? Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD." How do I buy shares of Rite Aid? Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Rite Aid's stock price today? One share of RAD stock can currently be purchased for approximately $17.29. How big of a company is Rite Aid? Rite Aid has a market capitalization of $945.81 million and generates $21.93 billion in revenue each year. The company earns $-452,170,000.00 in net income (profit) each year or $0.15 on an earnings per share basis. Rite Aid employs 48,000 workers across the globe. What is Rite Aid's official website? The official website for Rite Aid is www.riteaid.com. How can I contact Rite Aid? Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected] This page was last updated on 7/2/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
